1. 122 To determine ideal gross tumour volumes and PTV expansion using four-dimensional computed tomography for the treatment of lung cancer. (January 2016) Authors: Goyal, N.; Ingle, M.; Bhuva, N.; Power, D.; Lewanski, C. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 14LBA Atezolizumab monotherapy vs docetaxel in 2L/3L non-small cell lung cancer: Primary analyses for efficacy, safety and predictive biomarkers from a randomized phase II study (POPLAR). Issue 3 (September 2015) Authors: Vansteenkiste, J.; Fehrenbacher, L.; Spira, A.I.; Mazieres, J.; Park, K.; Smith, D.; Artal-Cortes, A.; Lewanski, C.; Braiteh, F.; Yi, J.; He, P.; Kowanetz, M.; Waterkamp, D.; Ballinger, M.; Chen, D.S.; Sandler, A.; Rittmeyer, A. Journal: European journal of cancer Issue: Volume 51:Issue 3(2015:Feb.) Page Start: S716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 74: TRANSCRiPT: a study to assess Tarceva® in NSCLC with epidermal growth factor receptor mutations. (January 2015) Authors: Lewanski, C.; Hennig, I.M.; Muthukumar, D.M.; Benepal, T.; Tahir, S.; Garcia, A.; Summerhayes, M.; De Queiros, S.K. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗